Equibles does not estimate personal net worth.
Get an email with a short summary when LifeMD, Inc. publishes a filing, an earnings call transcript or a press release.
Get LFMD alertsAtul Kavthekar is recorded as CFO at LifeMD, Inc. (LFMD) and CFO at P3 Health Partners Inc. (PIII) since December 12, 2022. The newest filing on record that lists Atul Kavthekar as CFO at LifeMD, Inc. (LFMD) is dated April 30, 2026. LifeMD, Inc. reported in an 8-K filed March 18, 2026 that Atul Kavthekar was appointed Chief Financial Officer, effective March 16, 2026. P3 Health Partners Inc. reported in an 8-K filed August 29, 2024 that Atul Kavthekar resigned as Chief Financial Officer, effective October 1, 2024. P3 Health Partners Inc. reported in an 8-K filed December 1, 2022 that Atul Kavthekar was appointed Chief Financial Officer, effective December 12, 2022. The proxy statement of P3 Health Partners Inc. reports total compensation of $682,247 for Atul Kavthekar in fiscal 2024, including a base salary of $380,126. Disclosed compensation is on record for 3 fiscal years. Atul Kavthekar has spoken on 8 earnings calls across 2 companies, most recently for LifeMD, Inc. on August 5, 2026. Those appearances were for P3 Health Partners Inc. (PIII) and LifeMD, Inc. (LFMD). P3 Health Partners Inc. is classified in the Medical Care Facilities industry within the Healthcare sector. LifeMD, Inc. is classified in the Health Information Services industry within the Healthcare sector. Other leadership on record at P3 Health Partners Inc. includes Aric Coffman (CEO and Board Member), Aric Coffman, M.D. (CEO), Mark Thierer (Chairman and Board Member) and 7 others.
“On March 16, 2026, the Company publicly announced the appointment of Atul Kavthekar as its new Chief Financial Officer, effective on that date.”
“Mr. Pedersen will succeed Atul Kavthekar, who resigned from his position as Chief Financial Officer of the Company effective as of the Effective Date.”
“As a reminder, all year-over-year comparisons are on a continuing operations basis, excluding WorkSimply, which was divested on November 4, 2025.”
“I’ll begin today by reviewing our recent quarter and our progress towards achieving our full-year guidance. Following that, I’ll share updates on our liquidity position as of the end of the quarter.”
“I will start today by discussing our recent quarter and how we are progressing towards our full year guidance. Then I'll provide updates on our liquidity position at the end of the quarter.”
“Sherif hit the highlights, but I want to provide a bit more detail on the fourth quarter and the full year 2023 results, which brought us below our full year EBITDA guidance we confirmed in early January 2024.”
“I'll start by discussing our recent quarter and how we are progressing towards meeting our full year guidance. Then I'll provide updates on our liquidity position and our significantly lower cash burn in the quarter, and finish up with some thoughts around our preliminary 2024 adjusted EBITDA guidance.”
2022-12-12–present
Start not stated–present
Last confirmed April 30, 2026
Start not stated–2024-10-01
Medical Care Facilities · Healthcare
CFO
2022-12-12–present
LFMD
Health Information Services · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | P3 Health Partners Inc. (PIII) | Former Chief Financial Officer | $380,126 | $682,247 |
| 2023 | P3 Health Partners Inc. (PIII) | Former Chief Financial Officer | $469,231 | $2,204,285 |
| 2022 | P3 Health Partners Inc. (PIII) | Chief Financial Officer | $17,308 | $1,364,117 |
